Molecular characterization of a purified 5-HT4 receptor -: A structural basis for drug efficacy

被引:121
作者
Banères, JL
Mesnier, D
Martin, A
Joubert, L
Dumuis, A
Bockaert, J
机构
[1] Fac Pharm Montpellier, CNRS, UMR 5074, F-34093 Montpellier, France
[2] Univ Montpellier 2, Univ Montpellier 1, INSERM U661, UMR 5203,CNRS, F-34094 Montpellier, France
[3] Inst Genom Fonct, Dept Neurobiol, F-34094 Montpellier, France
关键词
D O I
10.1074/jbc.M412009200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin 5-HT4(a) receptor, a G-protein-coupled receptor (GPCR), was produced as a functional isolated protein using Escherichia coli as an expression system. The isolated receptor was characterized at the molecular level by circular dichroism (CD) and steady-state fluorescence. A specific change in the near-UV CD band associated with the GPCR disulfide bond connecting the third transmembrane domain to the second extracellular loop (e2) was observed upon agonist binding to the purified receptor. This is a direct experimental evidence for a change in the conformation of the e2 loop upon receptor activation. Different variations were obtained depending whether the ligand was an agonist ( partial or full) or an inverse agonist. In contrast, antagonist binding did not induce any variation. These observations provide a first direct evidence for the fact that free ( or antagonist-occupied), active (partial- or full agonist-occupied) and silent (inverse agonist-occupied) states of the receptor involve different arrangements of the e2 loop. Finally, ligand-induced changes in the fluorescence emission profile of the purified receptor confirmed that the partial agonist stabilized a single, well-defined, conformational state and not a mixture of different states. This result is of particular interest in a pharmacological perspective since it directly demonstrates that the efficacy of a drug is likely due to the stabilization of a ligand-specific state rather than selection of a mixture of different conformational states of the receptor.
引用
收藏
页码:20253 / 20260
页数:8
相关论文
共 38 条
[1]   Direct observation of G-protein binding to the human δ-opioid receptor using plasmon-waveguide resonance spectroscopy [J].
Alves, ID ;
Salamon, Z ;
Varga, E ;
Yamamura, HI ;
Tollin, G ;
Hruby, VJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :48890-48897
[2]   Structure-based analysis of GPCR function:: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein [J].
Banères, JL ;
Parello, J .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (04) :815-829
[3]   Structure-based analysis of GPCR function:: Conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1 [J].
Baneres, JL ;
Martin, A ;
Hullot, P ;
Girard, JP ;
Rossi, JC ;
Parello, J .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (04) :801-814
[4]  
Bockaert J, 2002, INT REV CYTOL, V212, P63
[5]   Molecular tinkering of G protein-coupled receptors: an evolutionary success [J].
Bockaert, J ;
Pin, JP .
EMBO JOURNAL, 1999, 18 (07) :1723-1729
[6]   A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL) [J].
Claeysen, S ;
Joubert, L ;
Sebben, M ;
Bockaert, J ;
Dumuis, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :699-702
[7]   Cloning, expression and pharmacology of the mouse 5-HT4L receptor [J].
Claeysen, S ;
Sebben, M ;
Journot, L ;
Bockaert, J ;
Dumuis, A .
FEBS LETTERS, 1996, 398 (01) :19-25
[8]  
Dominguez J.-M., 1983, FORMULATION POTENTIA, V189
[9]  
Fasman, 1996, CIRCULAR DICHROISM C, P381
[10]   THE 5-HT4 RECEPTOR - MOLECULAR-CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF 2 SPLICE VARIANTS [J].
GERALD, C ;
ADHAM, N ;
KAO, HT ;
OLSEN, MA ;
LAZ, TM ;
SCHECHTER, LE ;
BARD, JA ;
VAYSSE, PJJ ;
HARTIG, PR ;
BRANCHEK, TA ;
WEINSHANK, RL .
EMBO JOURNAL, 1995, 14 (12) :2806-2815